GUFICBIO

Gufic Biosciences Share PriceGufic BioSciences

₹190.8
-3.2 (-1.65%)
As on 25 March, 2023 | 06:18 BSE: 509079 NSE: GUFICBIO

Gufic Biosciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Gufic BioSciences

Start SIP

Gufic Biosciences Share Price

  • Over 1 Month -10.4%
  • Over 3 Month -11.73%
  • Over 6 Month -14.46%
  • Over 1 Year -23.77%

Gufic Biosciences Key Statistics

P/E Ratio 22.6
PEG Ratio -3
Market Cap Cr 1,850
Price to Book Ratio 6.9
EPS 9.9
Dividend 0.1
Relative Strength Index 29.27
Money Flow Index 30.5
MACD Signal -4.51
Average True Range 5.78

Gufic Biosciences Investment Rating

  • Master Rating:
  • Gufic Biosciences has an operating revenue of Rs. 679.78 Cr. on a trailing 12-month basis. An annual revenue growth of 59% is outstanding, Pre-tax margin of 16% is great, ROE of 35% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Gufic BioSciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 177175165162
Operating Expenses Qtr Cr 144142132131
Operating Profit Qtr Cr 33333332
Depreciation Qtr Cr 5544
Interest Qtr Cr 2211
Tax Qtr Cr 7776
Net Profit Qtr Cr 20202120

Gufic Biosciences Technicals

EMA & SMA

Current Price
₹190.8
-3.2 (-1.65%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 201.22
  • 50 Day
  • 208.28
  • 100 Day
  • 212.56
  • 200 Day
  • 214.43
  • 20 Day
  • 202.82
  • 50 Day
  • 211.53
  • 100 Day
  • 214.72
  • 200 Day
  • 215

Gufic Biosciences Resistance and Support

PIVOT
₹195.2
Resistance
First Resistance 197.1
Second Resistance 200.2
Third Resistance 202.1
RSI 29.27
MFI 30.5
MACD Single Line -4.51
MACD -5.34
Support
First Resistance 192.1
Second Resistance 190.2
Third Resistance 187.1

Gufic Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 59,178 4,068,488 68.75
Week 64,115 3,656,490 57.03
1 Month 74,056 4,324,865 58.4
6 Month 115,873 5,998,743 51.77

Gufic Biosciences Result Highlights

Gufic BioSciences Synopsis

NSE-Medical-Generic Drugs

Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 779.16 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2022. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
Market Cap 1,843
Sales 680
Shares in Float 2.42
No of funds 11
Yield 0.05
Book Value 6.85
U/D Vol ratio 0.5
LTDebt / Equity 18
Alpha -0.07
Beta 0.71

Gufic BioSciences

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 75%75%75%
Mutual Funds 1.03%1.03%1.03%
Foreign Portfolio Investors 0.16%0.06%1.38%
Individual Investors 18.24%18.28%17.84%
Others 5.57%5.63%4.75%

Gufic BioSciences Management

Name Designation
Mr. Jayesh P Choksi Chairman & Managing Director
Mr. Pranav J Choksi WholeTime Director & CEO
Mr. Pankaj J Gandhi Whole Time Director
Mr. Dilip B Ghosh Whole Time Director
Dr. Balram H Singh Non Exe.Non Ind.Director
Mr. Rabi N Sahoo Independent Director
Mr. Gopal M Daptari Independent Director
Mr. Shreyas K Patel Independent Director
Mr. Shrirang V Vaidya Independent Director
Dr. Anu S Auora Independent Director

Gufic Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Gufic BioSciences MF Shareholding

Name Amount(cr)
SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl 1632
Motilal Oswal S&P BSE Healthcare ETF 6

Gufic BioSciences FAQs

What is Share Price of Gufic BioSciences ?

Gufic BioSciences share price is ₹190 As on 25 March, 2023 | 06:04

What is the Market Cap of Gufic BioSciences ?

The Market Cap of Gufic BioSciences is ₹1849.7 Cr As on 25 March, 2023 | 06:04

What is the P/E ratio of Gufic BioSciences ?

The P/E ratio of Gufic BioSciences is 22.6 As on 25 March, 2023 | 06:04

What is the PB ratio of Gufic BioSciences ?

The PB ratio of Gufic BioSciences is 6.9 As on 25 March, 2023 | 06:04

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number